WallStreetZenWallStreetZen

NASDAQ: GALT
Galectin Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

GALT earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$44.8M
Current Profit Margin
0%

GALT Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when GALT announces earnings.

GALT Return on Assets

Current Company
-197.7%
Current Industry
2.9%
GALT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GALT Return on Capital Employed

Current Company
-334.5%
Current Industry
19.5%
GALT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GALT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GALT$0.00-$41.86M-$44.81MN/AN/A
ABOS$0.00-$51.61M-$52.37MN/AN/A
CMPX$0.00-$40.60M-$42.49MN/AN/A
MACK$0.00-$1.17M-$1.18MN/AN/A
ATNM$81.00k-$48.03M-$48.82M-73.39%N/A
View Top Biotech Stocks

GALT earnings dates

Next earnings date
May 13, 2024

Galectin Therapeutics Earnings & Revenue FAQ

What were GALT's earnings last quarter?

On Invalid Date, Galectin Therapeutics (NASDAQ: GALT) reported Q4 2023 earnings per share (EPS) of -$0.16, up 11.11% year over year. Total Galectin Therapeutics earnings for the quarter were -$10.06 million. In the same quarter last year, Galectin Therapeutics's earnings per share (EPS) was -$0.18.

If you're new to stock investing, here's how to buy Galectin Therapeutics stock.

What was GALT's earnings growth in the past year?

As of Q2 2024, Galectin Therapeutics's earnings has grown year over year. Galectin Therapeutics's earnings in the past year totalled -$44.81 million.

What is GALT's earnings date?

Galectin Therapeutics's earnings date is Invalid Date. Add GALT to your watchlist to be reminded of GALT's next earnings announcement.

What was GALT's revenue last quarter?

On Invalid Date, Galectin Therapeutics (NASDAQ: GALT) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Galectin Therapeutics's revenue was $0.00.

What was GALT's revenue growth in the past year?

As of Q2 2024, Galectin Therapeutics's revenue has grown null year over year. Galectin Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.